Cytological method, molecular assays, quality and autopsy
Adequacy and preparation limit interpretation
A cytology report first considers whether the material represents the target and is adequate for the actual task. Low cellularity, blood, degeneration, crush or preparation artifact can change confidence. Conventional and liquid-based cervical preparations do not use an identical numerical adequacy threshold. The classification for a thyroid aspirate is distinct from cervical terminology, and an edition must be named when a threshold or risk range is examined. A descriptive category and the appropriate clinical follow-up are related but not interchangeable findings. Cytology can support a diagnosis without supplying every architectural feature available in an excision.
Preserve the biological information
Fixation, processing, staining and controls affect morphology and ancillary results. Crosslinking helps preserve tissue but can alter epitopes and nucleic acids. Decalcification can compromise different analytes, so the validated method is chosen for the actual specimen and planned assays. A breast biomarker handling window is not a universal mandate for every organ, analyte and molecular platform. Internal controls and appropriate external controls serve complementary roles. An expected control failing alongside the target can make a negative tumor result uninterpretable rather than evidence of true biological absence.
Molecular and circulating assays
DNA and RNA methods have complementary strengths, including different issues in variant and fusion detection. RNA quality, panel design, expression, coverage and validation affect performance. A break-apart assay can detect a relevant rearrangement without identifying every partner, but its limitations and possible partial events matter. Plasma analysis can detect a tumor alteration, while low shedding can produce false negatives. A mutation in a gene associated with clonal hematopoiesis is not automatically proven to arise from blood cells solely because of its name or allele fraction. Matched testing and the clinical context can be needed to establish origin.
Quality and autopsy reasoning
Precision, bias, reference intervals and diagnostic accuracy are different quantities. A high-sensitivity test can still have a low positive predictive value in a low-prevalence population. Kappa adjusts observed agreement for expected chance agreement rather than simply reporting a raw percentage. Quality tools identify risks and contributors, but a numerical priority score does not eliminate separate attention to a catastrophic failure. Autopsy interpretation integrates medical history, scene information, external and internal findings and appropriate ancillary testing. Lividity and rigor are processes, not exact universal clocks. A disease finding, mechanism of death and legally determined manner are distinct. Notification, authorization, tissue research and certification requirements depend on current local law and are not established here.